Promoting human health and safety by reducing exposures to risks and
harms through regulatory interventions is among the most important
responsibilities of the government. Such efforts encompass a wide array of
activities in many different contexts: improving air and water quality; safeguarding
the food supply; reducing the risk of injury on the job, in transportation,
and from consumer products; and minimizing exposure to toxic
chemicals. Estimating the magnitude of the expected health and longevity
benefits and reductions in mortality, morbidity, and injury risks helps policy
makers decide whether particular interventions merit the expected costs
associated with achieving these benefits and inform their choices among
alternative strategies. Valuing Health for Regulatory Cost-Effectiveness Analysis
provides useful recommendations for how to measure health-related quality of-
life impacts for diverse public health, safety, and environmental regulations.
Public decision makers, regulatory analysts, scholars, and students in
the field will find this an essential review text. It will become a standard reference
for all government agencies and those consultants and contractors
who support the work of regulatory programs.
- FrontMatter
- Reviewers
- Preface
- Acknowledgments
- Contents
- Executive Summary
- 1 Introduction
- 2 Characteristics of Major Regulations and Current Analytic Practices
- 3 Measures and Strategies for Obtaining Health Benefit Values for Regulatory Analysis
- 4 Beyond Ratios: Ethical and Nonquantifiable Aspects of Regulatory Decisions
- 5 Recommendations for Regulatory Cost-Effectiveness Analysis
- Appendixes
- A Summary of Case Studies
- B Health Indexes
- C OMB Circular A-4
- D Acronyms and Glossary
- E Biographical Sketches
- References
- Index
Connectez-vous à votre compte
